Cormorant Asset Management, LP's Form 4 filing
OnKure Therapeutics, Inc. (OKUR) · filed May 19, 2025
- Accession no.
- 0000929638-25-001950
- Filed
- May 19, 2025, 5:33 PM ET
- Trade date
- May 15, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $3.36M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | Other: Former 10% Owner |
| Chen BihuaCIK 0001599214 | Other: Former 10% Owner |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund III LPCIK 0001817320 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund IV LPCIK 0001871297 | Other: Former 10% Owner |
| Cormorant Private Healthcare Fund V LPCIK 0001969296 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Class A Common Stock | SSaleDisposed | −1,813,439 | $1.85 | −$3,363,022.63 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.